Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 4;21(9):3245.
doi: 10.3390/ijms21093245.

Human Ovarian Cortex biobanking: A Fascinating Resource for Fertility Preservation in Cancer

Affiliations
Review

Human Ovarian Cortex biobanking: A Fascinating Resource for Fertility Preservation in Cancer

Erica Silvestris et al. Int J Mol Sci. .

Abstract

Novel anti-cancer treatments have improved the survival rates of female young patients, reopening pregnancy issues for female cancer survivors affected by the tumor treatment-related infertility. This condition occurs in approximately one third of women of fertile age and is mainly dependent on gonadotoxic protocols, including radiation treatments. Besides routine procedures such as the hormonal induction of follicular growth and subsequent cryopreservation of oocytes or embryos, the ovarian protection by gonadotropin-releasing hormone (GnRH) agonists during chemotherapy as well as even gonadal shielding during radiotherapy, other innovative techniques are available today and need to be optimized to support their introduction into the clinical practice. These novel methods are hormone stimulation-free and include the ovarian cortex cryopreservation before anti-cancer treatments and its subsequent autologous reimplantation and a regenerative medicine approach using oocytes derived in vitro from ovarian stem cells (OSCs). For both procedures, the major benefit is related to the prompt recruitment and processing of the ovarian cortex fragments before gonadotoxic treatments. However, while the functional competence of oocytes within the cryopreserved cortex is not assessable, the in vitro maturation of OSCs to oocytes, allows to select the most competent eggs to be cryopreserved for fertility restoration.

Keywords: cryopreservation; gonadotoxicity; oncofertility; ovarian cortex; ovarian stem cells; tissue biobanking.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Anatomic location and structure of the ovary including cortical components.
Figure 2
Figure 2
Potential applications of whole ovary and cortex fragments cryopreservation and transplantation for fertility preservation.
Figure 3
Figure 3
Live birth rates obtained by traditional oocyte pick-up and cryopreservation (left) and novel techniques using ovarian cortex biopsies (right), as reported in literature.
Figure 4
Figure 4
In vitro maturation of ovarian stem cells (OSC)s to oocyte-like cells (OLCs) of large (red arrows) and small (black) size in three weeks cultures.

Similar articles

Cited by

References

    1. Inhorn M., Patrizio P. Infertility around the globe: New thinking on gender, reproductive technologies and global movements in the 21st century. Hum. Reprod. Update. 2015;21:411–426. doi: 10.1093/humupd/dmv016. - DOI - PubMed
    1. American Cancer Society Cancer Facts & Figures 2013. [(accessed on 17 January 2013)]; Available online: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts....
    1. Molina J., Barton D., Loprinzi C. Chemotherapy-induced ovarian failure - Manifestations and management. Drug Saf. 2005;28:401–416. doi: 10.2165/00002018-200528050-00004. - DOI - PubMed
    1. Akahori T., Woods D.C., Tilly J.L. Female Fertility Preservation through Stem Cell-based Ovarian Tissue Reconstitution in Vitro and Ovarian Regeneration in Vivo. Clin. Med. Insights Reprod. Health. 2019;13:1179558119848007. doi: 10.1177/1179558119848007. - DOI - PMC - PubMed
    1. Bedoschi G., Navarro P., Oktay K. Chemotherapy-induced damage to ovary: Mechanisms and clinical impact. Future Oncol. 2016;12:2333–2344. doi: 10.2217/fon-2016-0176. - DOI - PMC - PubMed